R Finkelstein, HD Ma, H Ghezzo, K Whittaker, RS Fraser and MG Cosio
Respiratory Division, Royal Victoria Hospital, Meakins Christie Laboratories, McGill University, Montreal, Quebec, Canada.

Based on our previous finding, of increased small airways disease in centrilobular emphysema (CLE) when compared with panlobular emphysema (PLE), we hypothesized that smokers who develop CLE would have increased airway responsiveness associated with airway inflammation and exaggerated airway narrowing, but not smokers with PLE. We compared preoperative methacholine challenge with the morphologic and cellular inflammatory characteristics of the airways in the lungs of six nonsmokers, 10 smokers with CLE, and five smokers with PLE. The airways of the CLE group were narrower than those of the nonsmokers (KS < 0.05) and the PLE group (KS < 0.05), but perimeters were not different. A greater percentage of airways in the CLE group showed infolding of the epithelium and lumen deformity than in the PLE group and nonsmokers (p < 0.05). Airway inner wall thickening (WI) was increased in the CLE group when compared with the PLE group and nonsmokers (p < 0.05), and WI correlated significantly with PC20 in the CLE group (r = -0.64, p < 0.01) but not in the PLE group and nonsmokers. The number of T lymphocytes in the airway walls correlated with PC20 in the CLE group (r = -0.50, p < 0.05) but not in the PLE group. In conclusion, despite similar age, smoking history, and range of airflow limitation, there was a clear difference in the methacholine responsiveness between the emphysema groups, suggesting that responsiveness is not just a reaction to smoking but either a reaction developing in some smokers or an abnormality initially present in some smokers which, in combination with exposure to cigarettes, determines the development of a type of lung disease: CLE.

This article has been cited by other articles:

				A. L. James and S. Wenzel Clinical relevance of airway remodelling in airway diseases Eur. Respir. J., July 1, 2007; 30(1): 134 - 155. [Abstract] [Full Text] [PDF]

				W.-D. Kim, S. H. Ling, H. O. Coxson, J. C. English, J. Yee, R. D. Levy, P. D. Pare, and J. C. Hogg The Association Between Small Airway Obstruction and Emphysema Phenotypes in COPD Chest, May 1, 2007; 131(5): 1372 - 1378. [Abstract] [Full Text] [PDF]

				M. M E Gosman, H Marike Boezen, C. C van Diemen, J. B Snoeck-Stroband, T. S Lapperre, P. S Hiemstra, N. H T ten Hacken, J. Stolk, D. S Postma, and the GLUCOLD Study Group A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology Thorax, March 1, 2007; 62(3): 242 - 247. [Abstract] [Full Text] [PDF]

				R O'Donnell, D Breen, S Wilson, and R Djukanovic Inflammatory cells in the airways in COPD Thorax, May 1, 2006; 61(5): 448 - 454. [Abstract] [Full Text] [PDF]

				I. Ito, S. Nagai, T. Handa, S. Muro, T. Hirai, M. Tsukino, and M. Mishima Matrix Metalloproteinase-9 Promoter Polymorphism Associated with Upper Lung Dominant Emphysema Am. J. Respir. Crit. Care Med., December 1, 2005; 172(11): 1378 - 1382. [Abstract] [Full Text] [PDF]

				K. F. Chung The Role of Airway Smooth Muscle in the Pathogenesis of Airway Wall Remodeling in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2005; 2(4): 347 - 354. [Abstract] [Full Text] [PDF]

				C. E. Girod and T. E. King Jr. COPD: A Dust-Induced Disease? Chest, October 1, 2005; 128(4): 3055 - 3064. [Abstract] [Full Text] [PDF]

				B.W.M. Willemse, N.H.T. ten Hacken, B. Rutgers, I.G.A.T. Lesman-Leegte, W. Timens, and D.S. Postma Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD Eur. Respir. J., September 1, 2004; 24(3): 391 - 396. [Abstract] [Full Text] [PDF]

				D. C. Grootendorst and K. F. Rabe Mechanisms of Bronchial Hyperreactivity in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2004; 1(2): 77 - 87. [Abstract] [Full Text] [PDF]

				A. Corsico, M. Milanese, S. Baraldo, G. L. Casoni, A. Papi, A. M. Riccio, I. Cerveri, M. Saetta, and V. Brusasco Small airway morphology and lung function in the transition from normality to chronic airway obstruction J Appl Physiol, July 1, 2003; 95(1): 441 - 447. [Abstract] [Full Text] [PDF]

				G T Verhoeven, J P J J Hegmans, P G H Mulder, J M Bogaard, H C Hoogsteden, and J-B Prins Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness Thorax, August 1, 2002; 57(8): 694 - 700. [Abstract] [Full Text] [PDF]

				M.G. Cosio Piqueras and M.G. Cosio Disease of the airways in chronic obstructive pulmonary disease Eur. Respir. J., July 2, 2001; 18(34_suppl): 41S - 49s. [Abstract] [Full Text] [PDF]

				J. Majo, H. Ghezzo, and M.G. Cosio Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema Eur. Respir. J., May 1, 2001; 17(5): 946 - 953. [Abstract] [Full Text] [PDF]

				G. T. Verhoeven, A. F.M. Verbraak, S. Boere-van der Straat, H. C. Hoogsteden, and J. M. Bogaard Influence of Lung Parenchymal Destruction on the Different Indexes of the Methacholine Dose-Response Curve in COPD Patients Chest, April 1, 2000; 117(4): 984 - 990. [Abstract] [Full Text] [PDF]

				M. G. COSIO and A. GUERASSIMOV Chronic Obstructive Pulmonary Disease . Inflammation of Small Airways and Lung Parenchyma Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): S21 - 25. [Abstract] [Full Text] [PDF]